Announced Thu, 2 Jul · 15:40 IST
Subsidiary store drug license suspended for 3 days in Bangalore
General View source PDF
MEDPLUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-0.4%1-day move
₹819.95
prior close
₹815.55
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.3-0.2-0.1—-0.4-0.5-0.7-1.1+0.6-1.1-11.9———
Up moveDown movePending
AI summary
Optival Health Solutions, a subsidiary of Medplus, received a suspension order for the Drug License of its Subramanyanagar Rajajinagar store in Bangalore from the Assistant Director, Drugs Control Administration. The suspension is for three days under Rule 65 of the Drugs and Cosmetics Act and Rules. Potential revenue loss from the three-day suspension is estimated at Rs 5.13 lakhs.
Likely market impact
Minor near-term revenue impact of about Rs 5.13 lakhs from a single store; unlikely to materially affect overall business.